Morepen Laboratories Profit & Loss Annual

Trade
BSE: 500288 | NSE: MOREPENLAB | ISIN: INE083A01026 | Sector: Biotechnology & Drugs
74.02 -0.03 (-0.04%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,690.431,417.531,546.831,188.06
Total Revenue 1,690.431,417.531,546.831,188.06
Costof Revenue Total 1,062.42970.371,060.94786.78
Gross Profit 628.01447.16485.89401.28
Selling/ General/ Admin Expenses Total 347.39293.70271.95225.24
Depreciation/ Amortization 33.4727.9327.6430.28
Other Operating Expenses Total 121.9970.8674.2651.88
Total Operating Expense 1,565.281,365.931,437.801,099.83
Operating Income 125.1651.60109.0388.23
Interest Inc( Exp) Net- Non- Op Total -37.10-3.2386.953.46
Other Net 13.974.488.989.93
Net Income Before Taxes 135.4255.76126.7098.51
Provisionfor Income Taxes 38.8017.0825.021.42
Net Income After Taxes 96.6238.68101.6897.09
Minority Interest -0.460.000.000.00
Net Income Before Extra Items 96.1638.68101.6897.09
Net Income 96.1638.68101.6897.09
Income Availableto Com Excl Extra Ord 96.1638.68101.6897.09
Income Availableto Com Incl Extra Ord 96.1638.68101.6897.09
Diluted Net Income 96.1638.68101.6897.09
Diluted Weighted Average Shares 51.1550.2251.9845.11
Diluted EPS Excluding Extra Ord Items 1.880.771.962.15
Diluted Normalized EPS 1.880.771.962.15
Research Development -30.6930.0856.46
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts